Patents by Inventor Hideaki Hoshi

Hideaki Hoshi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11915978
    Abstract: A first regrowth layer and a second regrowth layer comprising GaAs having high resistance are regrown on a surface of an etching stop layer exposed to the bottom of a first groove and a second groove, and then n-type InGaAs is regrown on the first regrowth layer and the second regrowth layer, whereby a source region and a drain region configured to make contact with a channel layer are formed in the first groove and the second groove respectively.
    Type: Grant
    Filed: November 15, 2019
    Date of Patent: February 27, 2024
    Assignee: Nippon Telegraph and Telephone Corporation
    Inventors: Takuya Hoshi, Yuki Yoshiya, Hiroki Sugiyama, Hideaki Matsuzaki
  • Patent number: 5066645
    Abstract: The present invention provides antitumor 4'-Demethylepipodophyllotoxin glycosides characterized by the fact that the glycoside moiety is altrose.
    Type: Grant
    Filed: September 1, 1989
    Date of Patent: November 19, 1991
    Assignee: Bristol-Myers Company
    Inventors: Takeshi Ohnuma, Hideaki Hoshi, Hideo Kamei, Takayuki Naito
  • Patent number: 4997931
    Abstract: The present invention relates to novel antitumor compounds which are 4'-demethylepipodophylloxtoxin derivatives. More particularly, the novel compounds are 4'-demethylepipodophyllotoxin allopyranosides, allofuranosides, and mannopyranosides.
    Type: Grant
    Filed: June 11, 1990
    Date of Patent: March 5, 1991
    Assignee: Bristol-Myers Squibb Company
    Inventors: Takeshi Ohnuma, Hideaki Hoshi
  • Patent number: 4699979
    Abstract: This invention provides novel cephalosporin intermediates, 7.beta.-amino-3-[(Z)-1-propen-1-y1]-3-cephem-4-carboxylic acid and esters thereof having the general formula ##STR1## wherein the configuration of the 3-propenyl group is Z sometimes referred to as cis- and R is hydrogen or a conventional carboxy-protected group, or a physiologically hydrolyzable esterifying group, and acid addition salts thereof and the metal salts of the foregoing substance wherein R is hydrogen. These compounds are useful as intermediates for preparation of orally active cephalosporins.
    Type: Grant
    Filed: March 25, 1986
    Date of Patent: October 13, 1987
    Assignee: Bristol-Meyers Company
    Inventors: Hideaki Hoshi, Jun Okumura, Takayuki Naito, Yoshio Abe, Shimpei Aburaki
  • Patent number: 4661590
    Abstract: 3-[(Z)-1-Propen-1-yl]-7-acylamido cephalosporins in which the 7-acyl group is phenylglycyl or substituted phenylglycyl are orally active antibiotics against Gram+ and Gram- bacteria.
    Type: Grant
    Filed: July 31, 1985
    Date of Patent: April 28, 1987
    Assignee: Bristol-Myers Company
    Inventors: Hideaki Hoshi, Jun Okumura, Takayuki Naito, Yoshio Abe, Shimpei Aburaki
  • Patent number: 4619925
    Abstract: The present invention relates to 7-[(D)-2-amino-2-(3-hydroxyphenyl)acetamido]-3-[(Z)-1-propenyl]-3-cephem-4 -carboxylic acid, which is an orally active antibiotic against Gram-positive and Gram-negative bacteria.
    Type: Grant
    Filed: November 8, 1985
    Date of Patent: October 28, 1986
    Assignee: Bristol-Myers Company
    Inventors: Hideaki Hoshi, Takayuki Naito
  • Patent number: 4591641
    Abstract: 3-[(Z)-1-Propen-1-yl]-7-acylamido cephalosporins in which the 7-acyl group is phenylglycyl or substituted phenylglycyl are orally active antibiotics against Gram+ and Gram- bacteria.
    Type: Grant
    Filed: March 18, 1985
    Date of Patent: May 27, 1986
    Assignee: Bristol-Myers Company
    Inventors: Hideaki Hoshi, Jun Okumura, Takayuki Naito, Yoshio Abe, Shimpei Aburaki
  • Patent number: 4520022
    Abstract: 3-[(Z)-1-Propen-1-yl]-7-acylamido cephalosporins in which the 7-acyl group is phenylglycyl or substituted phenylglycyl are orally active antibiotics against Gram+ and Gram- bacteria.
    Type: Grant
    Filed: December 28, 1983
    Date of Patent: May 28, 1985
    Assignee: Bristol-Myers Company
    Inventors: Hideaki Hoshi, Jun Okumura, Takayuki Naito, Yoshio Abe, Shimpei Aburaki
  • Patent number: 4299610
    Abstract: A method and an apparatus for manufacturing a crystalline blast furnace slag, which comprises: endlessly connecting at prescribed intervals a plurality of rectangular metal cooling bodies each with a hollow for cooling water, to form a plurality of cooling grooves with a width at the top end thereof of from 40 to 80 mm corresponding to said prescribed intervals and a depth of from 100 to 300 mm and becoming narrower toward the depth thereof, each between two adjacent ones of said cooling bodies; continuously pouring a molten blast furnace slag sequentially into said plurality of cooling grooves in an atmosphere of an inert gas and/or a reducing gas, while moving said plurality of cooling bodies endlessly connected in circulation in the connecting direction thereof; and, circulating a cooling water through said hollows for cooling water of said plurality of cooling bodies during the pouring of said molten blast furnace slag into said plurality of cooling grooves, to cool said plurality of cooling bodies, there
    Type: Grant
    Filed: March 25, 1980
    Date of Patent: November 10, 1981
    Assignee: Nippon Kokan Kabushiki Kaisha
    Inventors: Ryo Ando, Shigeru Araki, Hideaki Hoshi, Kazuyoshi Sato
  • Patent number: 4206116
    Abstract: The penicillin of the formula ##STR1## and its pharmaceutically acceptable salts and physiologically hydrolyzed esters possess antibacterial activity and are particularly valuable in treating Pseudomonas infections.
    Type: Grant
    Filed: December 7, 1978
    Date of Patent: June 3, 1980
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hideaki Hoshi
  • Patent number: 4198506
    Abstract: Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on- 6-ylthiomethyl)-3-cephem-4-carboxylic acids and their salts and easily hydrolyzed esters of the 4-carboxyl group were synthesized and found to be potent antibacterial agents which exhibited good aqueous solubility. A preferred embodiment was 7-[o-(methylaminomethyl)phenylacetamido]-3-(2-carboxyalkyl-2,3-dihydro-s-t riazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acid.
    Type: Grant
    Filed: March 21, 1979
    Date of Patent: April 15, 1980
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hajime Kamachi, Seiji Iimura, Hideaki Hoshi, Masahisa Oka
  • Patent number: 4151352
    Abstract: Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on- 6-ylthiomethyl)-3-cephem-4-carboxylic acids and their salts and easily hydrolyzed esters of the 4-carboxyl group were synthesized and found to be potent antibacterial agents which exhibited good aqueous solubility. A preferred embodiment was 7-[o-(methylaminomethyl)phenylacetamido]-3-(2-carboxyalkyl-2,3-dihydro-s-t riazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acid.
    Type: Grant
    Filed: February 13, 1978
    Date of Patent: April 24, 1979
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hajime Kamachi, Seiji Iimura, Hideaki Hoshi, Masahisa Oka
  • Patent number: 4082912
    Abstract: Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on- 6-ylthiomethyl)-3-cephem-4-carboxylic acids and their salts and easily hydrolyzed esters of the 4-carboxyl group were synthesized and found to be potent antibacterial agents which exhibited good aqueous solubility. A preferred embodiment was 7-[o-(methylaminomethyl)phenylacetamido]-3-(2-carboxyalkyl-2,3-dihydro-s-t riazolo[4,3-b]pyridazin-3-on-6-ylthiomethyl)-3-cephem-4-carboxylic acid.
    Type: Grant
    Filed: April 5, 1977
    Date of Patent: April 4, 1978
    Assignee: Bristol-Myers Company
    Inventors: Takayuki Naito, Jun Okumura, Hajime Kamachi, Seiji Iimura, Hideaki Hoshi, Masahisa Oka